JEAN TAGGART: Open Payments
NPI 1497465942 · MASON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 12 payments from 8 companies in 2025. Trend: 2023 $1,722 · 2024 $896 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $70 |
| ABBVIE INC. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| KYOWA KIRIN, INC. | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
Products named: REPATHA, CRENESSITY, GVOKE HYPOPEN, UBRELVY, Yorvipath, Dexcom G6 Transmitter, LINZESS, CRYSVITA.
Industry payments across OH — which companies pay providers there.
